Beattie I A, Swaminathan B, Ziegler H K
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322.
Infect Immun. 1990 Sep;58(9):2792-803. doi: 10.1128/iai.58.9.2792-2803.1990.
To explore the molecular basis of the T-cell-mediated immune response to Listeria monocytogenes, we cloned and expressed listerial antigens in Escherichia coli using the lambda-ZAP bacteriophage and Bluescript plasmid vectors. A two-stage screening strategy was implemented to identify T-cell-reactive antigens; the first stage involved antibodies or oligonucleotide probes and the second stage was based on assays for T-cell activation. A library of genomic DNA from L. monocytogenes was generated in lambda-ZAP, and then antigens, were detected in infected cells with a polyclonal rabbit anti-L. monocytogenes antiserum and an L. monocytogenes-specific monoclonal antibody. Also, synthetic oligonucleotide probes corresponding to the structural gene for listeriolysin O (LLO) were used to screen the recombinant DNA library. In each case, positive isolates were evaluated for T-cell antigenicity by measuring antigen-induced interleukin-2 production by polyclonal T cells taken from L. monocytogenes-immune mice. Phage clones were subcloned and expressed in the Bluescript plasmid and tested further for antigenic activity and LLO expression. Using this screening strategy, we successfully identified bacterial clones producing recombinant listerial antigens which activate L. monocytogenes-immune T cells in vitro. Antigens operative in the T-cell response during infection with L. monocytogenes include LLO, 62- and 39-kilodalton proteins, and other poorly defined bacterial surface components. We also found that high concentrations of recombinant LLO inhibited macrophage-mediated antigen presentation. These results are discussed in terms of the multiple functions of LLO as a virulence factor, inhibitor of antigen presentation, and potent antigen in the T-cell response to L. monocytogenes. These studies represent the first step toward a genetic definition of the antigens recognized in immune defense to L. monocytogenes.
为了探究T细胞介导的对单核细胞增生李斯特菌免疫反应的分子基础,我们使用λ-ZAP噬菌体和蓝Script质粒载体在大肠杆菌中克隆并表达李斯特菌抗原。实施了两阶段筛选策略来鉴定T细胞反应性抗原;第一阶段涉及抗体或寡核苷酸探针,第二阶段基于T细胞活化检测。在λ-ZAP中构建了单核细胞增生李斯特菌的基因组DNA文库,然后用多克隆兔抗单核细胞增生李斯特菌抗血清和单核细胞增生李斯特菌特异性单克隆抗体在感染细胞中检测抗原。此外,使用与溶菌酶O(LLO)结构基因对应的合成寡核苷酸探针筛选重组DNA文库。在每种情况下,通过测量从单核细胞增生李斯特菌免疫小鼠获取的多克隆T细胞中抗原诱导的白细胞介素-2产生,来评估阳性分离株的T细胞抗原性。噬菌体克隆被亚克隆并在蓝Script质粒中表达,并进一步测试其抗原活性和LLO表达。使用这种筛选策略,我们成功鉴定出产生重组李斯特菌抗原的细菌克隆,这些抗原在体外可激活单核细胞增生李斯特菌免疫T细胞。在单核细胞增生李斯特菌感染期间参与T细胞反应的抗原包括LLO、62千道尔顿和39千道尔顿蛋白,以及其他定义不明确的细菌表面成分。我们还发现高浓度的重组LLO抑制巨噬细胞介导的抗原呈递。就LLO作为毒力因子、抗原呈递抑制剂以及在对单核细胞增生李斯特菌的T细胞反应中的强效抗原的多种功能对这些结果进行了讨论。这些研究代表了对单核细胞增生李斯特菌免疫防御中识别的抗原进行基因定义的第一步。